Hair removal treatment
DeviceAxilla and bikini line hair removal treatments using the Trio Laser Module (Alma Lasers).
NCT Number: NCT04599751
The study is aimed to assess the safety and efficacy of hair removal treatments, using the Trio Laser Module (Alma Lasers).
The study will include 36 subjects that will undergo axilla and bikini line hair removal treatments. Safety and efficacy will be evaluated 3- months after the last treatment.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Skin Care Research, LLC, Hollywood, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Axilla and bikini line hair removal treatments using the Trio Laser Module (Alma Lasers).
Time frame: 3 month after the last treatment
Change in hair count, preformed by blinded evaluators, based on photographs taken at 3m FU visit compared to baseline
Time frame: Through study completion, an average of 1 year
Adverse events and serious AE reported at any time during the trial or follow-up
Time frame: up to 24 weeks
The investigator will assess the treatment area and score treatment related side effects using a 5-point likert scale, before and after the treatment
Time frame: up to 24 weeks
Subjects will be requested to scale any sensation of stinging, tingling, itching and, burning using the 5-point Likert scale, before and after the treatment
Time frame: up to 24 weeks
Subjects will be requested to scale their treatment related pain
Time frame: 3 months after the last treatment
Subjects will be requested to scale their satisfaction from the treatment
Alma Lasers
Industry
The Safety and Efficacy of Trio Diode Laser Module for Hair Removal Treatment in All Skin Types
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.